Concurrent Amplification of Ferroptosis and Immune System Activation Via Nanomedicine‐Mediated Radiosensitization for Triple‐Negative Breast Cancer Therapy
Advanced Science · 2025-02 · 12 (7)
DOI: 10.1002/advs.202407833 ↗Kurz gefasst
Fachartikel in der Zeitschrift Advanced Science, online erschienen am 25.12.2024. Verfasst von Reyida Aishajiang und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Radiotherapy, The Second Hospital of Jilin University, Changchun, 130022, China. Hauptthemen laut MEDLINE: Ferroptosis, Triple Negative Breast Neoplasms, Nanomedicine, Radiation-Sensitizing Agents. Die Arbeit wurde bisher 33-mal zitiert (Crossref) und nennt 44 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural Science Foundation of China, Jilin Province Youth Science and Technology Talent support project, Jilin Provincial Health and Family Planning Commission.
Abstract (Originalsprache)
Radiation therapy (RT) is one of the core therapies for current cancer management. However, the emergence of radioresistance has become a major cause of radiotherapy failure and disease progression. Therefore, overcoming radioresistance to achieve highly effective treatment for refractory tumors is significant yet challenging. Here, pH‐responsive DSPE‐PEoz modified hollow Bi 2 Se 3 ‐RSL3/diABZi (DP‐HBN/RA) nanomedicine is designed as a radiation sensitizer for efficient treatment of triple‐negative breast cancer by simultaneously amplifying ferroptosis and immune system activation. DP‐HBN/RA can efficiently concentrate X‐ray radiation energy inside the tumor, thereby promoting precise ionizing radiation exposure in tumor cells to produce large amounts of reactive oxygen species (ROS), leading to lipid peroxidation‐induced ferroptosis. Meanwhile, ferroptotic cell death is intensified through the inactivation of GPX4 by RSL3 released from DP‐HBN/RA to acidic conditions in the tumor microenvironment. Additionally, DP‐HBN/RA enhances RT efficacy to exacerbate unrepairable DNA damage and release DNA fragments that activate the cGAS‐STING signal pathway, evoking a systematic immune response. Ingeniously, the released diABZi reinforces cGAS‐STING activation to boost the immunology antitumor effect. This work links the induction of ferroptosis and the initiation of systematic immune response to achieve highly effective tumor suppression, which opens up new avenues for future treatments of refractory tumors.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Radiotherapy, The Second Hospital of Jilin University, Changchun, 130022, China.
- State Key Laboratory of Rare Earth Resource Utilization, Changchun Institute of Applied Chemistry, Chinese Academy of Sciences, Changchun, Jilin, 130022, China.
- School of Applied Chemistry and Engineering, University of Science and Technology of China, Hefei, Anhui, 230026, China.
ORCID-Profile: Reyida Aishajiang, Pengpeng Lei, Tiejun Wang, Duo Yu
Förderung
- National Natural Science Foundation of China
- Jilin Province Youth Science and Technology Talent support project
- Jilin Provincial Health and Family Planning Commission
- Jilin Province Development and Reform Commission
- Jilin Provincial Scientific and Technological Development Program
Zitieren
APA
Aishajiang, R., Liu, Z., Liang, Y., Du, P., Wei, Y., Zhuo, X., Liu, S., Lei, P., Wang, T., & Yu, D. (2025). Concurrent Amplification of Ferroptosis and Immune System Activation Via Nanomedicine‐Mediated Radiosensitization for Triple‐Negative Breast Cancer Therapy. Advanced Science, 12(7). https://doi.org/10.1002/advs.202407833
Vancouver
Aishajiang R, Liu Z, Liang Y, Du P, Wei Y, Zhuo X, et al. Concurrent Amplification of Ferroptosis and Immune System Activation Via Nanomedicine‐Mediated Radiosensitization for Triple‐Negative Breast Cancer Therapy. Advanced Science. 2025;12(7). doi:10.1002/advs.202407833
BibTeX
@article{Aishajiang2025,
author = {Aishajiang, Reyida and Liu, Zhongshan and Liang, Yuan and Du, Pengye and Wei, Yi and Zhuo, Xiqian and Liu, Shuyu and Lei, Pengpeng and Wang, Tiejun and Yu, Duo},
title = {Concurrent Amplification of Ferroptosis and Immune System Activation Via Nanomedicine‐Mediated Radiosensitization for Triple‐Negative Breast Cancer Therapy},
journal = {Advanced Science},
year = {2025},
volume = {12},
number = {7},
doi = {10.1002/advs.202407833}
}
EUVIMED